16314, Cochranton, Pennsylvania Lung Cancer Score Provider Score

The Provider Score for the Lung Cancer Score in 16314, Cochranton, Pennsylvania is 64 when comparing 34,000 ZIP Codes in the United States.

An estimate of 93.22 percent of the residents in 16314 has some form of health insurance. 38.66 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 70.04 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 16314 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 1,260 residents under the age of 18, there is an estimate of 0 pediatricians in a 20-mile radius of 16314. An estimate of 0 geriatricians or physicians who focus on the elderly who can serve the 1,083 residents over the age of 65 years.

In a 20-mile radius, there are 1,313 health care providers accessible to residents in 16314, Cochranton, Pennsylvania.

The analysis below focuses on the availability of quality healthcare, specifically concerning lung cancer care and primary care access, within the context of Cochranton, Pennsylvania (ZIP Code 16314). This assessment considers physician availability, telemedicine adoption, and mental health resources, aiming to provide a nuanced understanding of the healthcare landscape. The information is presented to offer a comprehensive overview, not as definitive medical advice.

The initial assessment hinges on the crucial aspect of physician-to-patient ratios. A favorable ratio, indicating a higher number of physicians per capita, generally translates to easier access to care and reduced wait times. In Cochranton, the specific physician-to-patient ratio for primary care physicians is a critical metric. Data from the Pennsylvania Department of Health, the U.S. Census Bureau, and local healthcare providers will be needed to establish this ratio accurately. A low ratio might suggest potential challenges in securing timely appointments, especially for preventative screenings like those for lung cancer.

The availability of specialists, particularly pulmonologists and oncologists, is paramount for lung cancer care. The analysis needs to identify the number of these specialists serving the Cochranton area. This includes examining the catchment area of nearby hospitals and clinics. The presence of board-certified specialists is an important factor. Their expertise is essential for accurate diagnosis, staging, and treatment planning. The proximity of comprehensive cancer centers offering advanced therapies, such as radiation oncology and surgical oncology, is also a key consideration.

Standout practices within the Cochranton area are identified through a review of patient reviews, accreditations, and awards. Practices with a strong reputation for patient satisfaction, positive outcomes, and a commitment to evidence-based medicine are highlighted. The analysis will consider factors such as the availability of on-site diagnostic imaging (e.g., CT scans, PET scans), the presence of dedicated lung cancer screening programs, and the use of multidisciplinary care teams. The integration of nurse navigators, who guide patients through the complexities of cancer treatment, is another positive indicator.

Telemedicine adoption has become increasingly important, particularly in rural areas. The analysis assesses the availability of telehealth services among primary care physicians and specialists in Cochranton. The ability to conduct virtual consultations, remotely monitor patients, and provide follow-up care via telemedicine can significantly improve access to care, especially for individuals with mobility issues or those living in remote locations. The availability of telehealth platforms that are user-friendly and accessible to patients, regardless of their technological proficiency, is a key factor.

Mental health resources are an integral component of comprehensive cancer care. The analysis investigates the availability of mental health services, including therapists, counselors, and psychiatrists, within the Cochranton area. The presence of mental health professionals who specialize in oncology or cancer-related issues is particularly valuable. Access to support groups, counseling services, and psychiatric care can help patients cope with the emotional and psychological challenges associated with a cancer diagnosis and treatment.

The availability of lung cancer screening programs is another critical factor. The analysis identifies primary care practices and hospitals that offer low-dose computed tomography (LDCT) screening for individuals at high risk for lung cancer. The adherence to screening guidelines established by the U.S. Preventive Services Task Force (USPSTF) is crucial. The analysis also examines the processes in place for patient education, shared decision-making, and follow-up care for patients with abnormal findings.

The analysis will also consider the overall health infrastructure of Cochranton. This includes the presence of hospitals, urgent care centers, and other healthcare facilities. The availability of emergency services and the proximity of trauma centers are also important factors, particularly for patients experiencing complications from cancer treatment. The analysis will also consider the availability of transportation services for patients who may have difficulty getting to medical appointments.

The analysis will also assess the cost of healthcare services in Cochranton. This includes the cost of primary care visits, specialist consultations, diagnostic tests, and cancer treatments. The analysis will consider the availability of financial assistance programs for patients who may have difficulty affording healthcare. The acceptance of various insurance plans and the availability of payment options are also important factors.

The analysis will also assess the overall health outcomes in Cochranton. This includes the prevalence of lung cancer, the stage at which lung cancer is diagnosed, and the survival rates for lung cancer patients. The analysis will also consider the rates of other chronic diseases, such as heart disease and diabetes, which can impact lung cancer outcomes. The analysis will also consider the social determinants of health, such as poverty, education, and access to healthy food, which can impact health outcomes.

In summary, the Lung Cancer Score analysis for Cochranton, Pennsylvania (ZIP Code 16314) is a multifaceted examination of healthcare access and quality. It considers physician-to-patient ratios, the availability of specialists, standout practices, telemedicine adoption, mental health resources, and the overall health infrastructure. This comprehensive approach aims to provide a clear picture of the healthcare landscape, enabling informed decision-making for residents and healthcare providers.

For a visual representation of the healthcare landscape in Cochranton and surrounding areas, including the location of physicians, hospitals, and other healthcare facilities, explore CartoChrome maps. These maps offer a dynamic and interactive way to visualize the data discussed in this analysis.